Downstream Processing Featured Articles

  1. Critical Innovation Bioprocessing Trends For 2014 12/12/2013

    How the most critical innovations will affect the industry future with the efforts to reduce the costs of manufacturing a biologic, according to the 10th Annual Report and Survey of Biopharmaceutical Manufacturers.

  2. Sanford-Burnham Research Projects Selected To Go To Space 11/29/2012

    We’re excited to announce recently that two of our research teams have won Space Florida’sInternational Space Station (ISS) Research Competition. Eight teams were selected from a pool of international applicants to send experiments to space in late 2013.

  3. Study Points To Possible Cause Of, And Treatment For, Non-Familial Parkinson's 2/6/2013

    Columbia University Medical Center (CUMC) researchers have identified a protein trafficking defect within brain cells that may underlie common non-familial forms of Parkinson’s disease.

  4. Single-Use Devices — What's REALLY Holding Up Adoption? 8/1/2011

    Today, single-use products have pushed beyond early-stage applications. However, single-use devices still need to address a number of problems in GMP commercial-scale operations. By Eric Langer, president and managing partner, BioPlan Associates, Inc.

  5. Single-Use Tubing And Filter/Tubing Assemblies 4/27/2011
    Meissner’s BioFlex™ fluid path assemblies are designed for secure fluid transfer in critical biopharmaceutical processing applications. These single-use tubing and filter/tubing assemblies offer maximum convenience and flexibility in single-use systems.
  6. New Strategy Prevents Rheumatoid Arthritis In Mice 2/8/2013

    Dana-Farber Cancer Institute scientists have demonstrated a new strategy for treating autoimmune disease that successfully blocked the development of rheumatoid arthritis in a mouse model.

  7. Biosensors & Big Data: Implications For Biologics Developers 10/13/2020

    Dr. Caroline Loew’s company, Glympse Bio, develops injectable, tunable biosensors that she says will help biologics developers test and measure disease progression in vivo, enabling valuable, early visibility into therapeutic efficacy. 

  8. Tiny Capsule Effectively Kills Cancer Cells 2/6/2013

    A tiny capsule invented at a UCLA lab could go a long way toward improving cancer treatment.

  9. Nearly 1,000 Medicines In Development To Help Patients In Their Fight Against Cancer 5/31/2012

    America’s biopharmaceutical research companies are testing 981 medicines and vaccines to fight the many types of canceraffecting millions of patients worldwide, according to a report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

  10. New CU-Boulder Discoveries Hold Promise For Treatment Of Hepatitis B Virus Infection 10/22/2012

    A University of Colorado Boulder-led team has discovered two prime targets of the Hepatitis B virus in liver cells, findings that could lead to treatment of liver disease in some of the 400 million people worldwide currently infected with the virus.